DURHAM, N.C. (AP) _ Argos Therapeutics Inc. (ARGS) on Monday reported a loss of $6.5 million in its second quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 61 cents.

The biotechnology company posted revenue of $54,200 in the period. Its adjusted revenue was $54,000.

The company's shares closed at 13 cents. A year ago, they were trading at $3.75.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARGS at https://www.zacks.com/ap/ARGS